Aligos Therapeutics Inc (ALGS) institutional holders · rev $2.2M
Aligos Therapeutics Inc institutional holders from SEC Form 13F, top 2 by reported value. Each row is the filer's newest 13F for quarters ended 2026-03-31 or later, share lines summed, options excluded; value is the 13F-reported market value in US dollars. Rows marked Prior quarter are filers whose 2026-06-30 13F is not cached yet.
| Holder | Shares | Value | Report |
|---|---|---|---|
| CITADEL ADVISORS LLC | 54,311 | $403.5K | 2026-03-31Prior quarter |
| FMR LLC | 10 | $0.06K | 2026-06-30 |
ALGS institutional holders FAQ
How many ALGS 13F holders are listed on this page?
This page lists 1 cached Aligos Therapeutics Inc (ALGS) 13F holder. Holders: https://lician.com/institutional/algs
Who is the largest ALGS 13F holder by reported value?
The largest cached 13F holder by reported value on this page is FMR LLC. Filer: https://lician.com/institutional/algs/315066. Holders: https://lician.com/institutional/algs
What value and shares did the largest ALGS 13F holder report?
FMR LLC, the largest cached 13F holder by reported value on this page, reported 10 shares and a value of $0.06K.
What is the latest ALGS 13F report date on this page?
The latest cached 13F report date on this Aligos Therapeutics Inc (ALGS) holders table is Jun 30, 2026.
Where are ALGS institutional holders listed?
Cached 13F holders for Aligos Therapeutics Inc (ALGS) are listed at https://lician.com/institutional/algs. Filer directory: https://lician.com/holders
What is ALGS's latest revenue?
Latest cached Aligos Therapeutics Inc (ALGS) revenue for Dec 31, 2025 was $2.2M. Statements: https://lician.com/financials/algs
Not investment advice. Figures as filed or reported, not a live feed.